The FDA recently warned the public about CBD health risks and urged further research. Meanwhile, special interest groups are pressing Congress and the FDA for quick action to allow CBD in dietary supplements and other consumer products.
Hydroxychloroquine and azithromycin versus COVID-19: Grift, conspiracy theories, and another bad study by Didier Raoult
On Friday, Prof. Didier Raoult posted another study of azithromycin and hydroxychloroquine used against COVID-19. It is a single arm observational study of patients with mostly mild (or even asymptomatic) disease that is painfully uninformative with respect to the question of this treatment's effectiveness. That didn't stop America's Quack Dr. Oz and other grifters from touting Raoult's study, as well as a...
The FDA and Nebraska health authorities issued warnings after patients became seriously ill following treatment with exosomes, an unproven, potentially risky and, per the FDA, illegal product being promoted by dubious stem cell clinics.
The FDA may strengthen homeopathic drug regulation with its "risk-based" enforcement policy, but this still leaves illegal homeopathic remedies on the market and falls far short of actually enforcing the law.
Drug shortages, which worsen medical care and patient outcomes, are becoming more and more common. A new Task Force report from the FDA offers a potential way forward.
Based on a thorough review of the evidence by experts, the FDA is proposing a ban on using curcumin, cesium chloride and other naturopathic favorites in compounded drugs.
Federal “right-to-try” over a year later: Still a failure and still about the money (and weakening the FDA)
Federal "right-to-try" legislation was passed and signed into law by President Trump over a year ago. Advocates promised that lots of terminally ill people who were dying then would be saved by having the right to "try" experimental therapies outside of the context of clinical trials. That has not happened. This should come as no surprise, because right-to-try was never about getting...
Generic drugs are supposed to be equivalent to brand-name drugs, but all too often they are defective. Katherine Eban's book shows that corrupt overseas manufacturers have committed intentional global fraud. The system is broken and the FDA lacks the power to correct abuses.
There's no reliable evidence that an infusion of blood plasma from a young donor will benefit an older person, and there are risks, but Ambrosia Health is selling "young blood" infusions for thousands of dollars anyway. The FDA has taken notice.
Over twenty years ago, cancer quack Stanislaw Burzynski pioneered the abuse of the clinical trial process as a marketing tool to sell his antineoplastons. Now, for-profit stem cell clinics are using ClinicalTrials.gov as a marketing tool for their unproven therapies by listing dubious and scientifically worthless trials in this government database. What can be done?